Columbia University’s acting president Claire Shipman is defending the school’s controversial $200 million settlement with the Trump administration, calling the agreement a “responsible path” to protect academic integrity and restore access to billions in federal research funding. The deal comes after months of negotiations following allegations of anti-Semitism on campus and the freezing of federal support for unrelated scientific research.
The settlement, announced earlier this week, makes Columbia the first university to reach an agreement with the Trump administration over its handling of campus discrimination claims. Under the terms, the university will pay more than $220 million over three years but will not be required to admit wrongdoing. In exchange, the federal government will lift its freeze on research funding—funding that supports medical and technological breakthroughs and fuels the university’s role as a top-tier research institution.
In her first television interview since the announcement, Shipman told CNN that the decision was not taken lightly. “This resolution is going to allow us to turn a page on a period of deep instability for our institution,” she said. “The stakes were high—not just for Columbia, but for science and innovation nationwide.”
The Trump administration claimed that Columbia violated anti-discrimination laws, specifically with Jewish students. In retaliation, the Trump administration cut off hundreds of millions of dollars in research funding with zero connection to their claims. This essentially froze the university’s entire scientific infrastructure.
Critics have accused Columbia of capitulating to political pressure and legitimizing what some see as a dangerous precedent—using funding freezes as leverage in ideological battles. Shipman pushed back on that narrative, calling it “too simplistic.”
“This was not courage versus capitulation,” she said. “It was an extraordinarily difficult decision, and one we made only after exhausting every possible option, including legal recourse.”
Unlike Harvard, which has pursued litigation against similar funding threats, Columbia chose to negotiate, fearing that even a legal victory could result in permanent damage to its relationship with the federal government. “We could have won a short-term fight in court,” Shipman said, “but lost our ability to conduct research for years to come.”
When asked whether President Trump was personally involved in the negotiations, Shipman said she had no direct knowledge but believed he was kept informed. Trump later celebrated the agreement online, praising Columbia for “doing what is right.”
While responding to concerns over whether or not the deal comprises academic and personal freedom on the Columbia campus, Shipman said, “Free expression is a bedrock principle at Columbia. We will always defend it—unless it veers into discrimination, harassment, or disruption.”
Shipman, who stepped into the role of acting president in March, acknowledged that the university faces difficult questions ahead, while stating that the agreement has nothing to do with Columbia’s values.
“This moment is bigger than Columbia,” she said. “It’s a turning point for higher education and our relationship with government oversight. We chose to listen, we chose to protect our community—and we stand by that choice.”
